|
|
Annie Bourdeau, Daniel J. Dumont, Michelle Letarte
J Clin Invest. 1999;
104(10):1343
doi:10.1172/JCI8088
Abstract |
Full text
| PDF

E
ndoglin (CD105), an accessory protein of the TGF-β receptor superfamily, is highly expressed on endothelial cells. Hereditary hemorrhagic telangiectasia type 1 (HHT1) is associated with mutations in the Endoglin gene, leading to haploinsufficiency. To generate a disease model and ascertain the role of endoglin in development, we generated mice lacking 1 or both copies of the gene. Endoglin null embryos die at gestational day 10.0–10.5 due to defects in vessel and heart development. Vessel formation appears normal until hemorrhage occurs in yolk sacs and embryos. The primitive vascular plexus of the yolk sac fails to mature into defined vessels, and vascular channels dilate and rupture. Internal bleeding is seen in the peritoneal cavity, implying fragile vessels. Heart development is arrested at day 9.0, and the atrioventricular canal endocardium fails to undergo mesenchymal transformation and cushion-tissue formation. These data suggest that endoglin is critical for both angiogenesis and heart valve formation. Some heterozygotes, either with an inbred 129/Ola or mixed C57BL/6-129/Ola background, show signs of HHT, such as telangiectases or recurrent nosebleeds. In this murine model of HHT, it appears that epigenetic factors and modifier genes, some of which are present in 129/Ola, contribute to disease heterogeneity.J. Clin. Invest. 104:1343–1351 (1999).
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(84)
| Title and authors |
Publication |
Year |
Liver Involvement in Osler-Weber-Rendu Disease (Hereditary Hemorrhagic Telangiectasia)
Martin Caselitz, Siegfried Wagner, Michael P. Manns
|
Zakim and Boyer s Hepatology
|
2012 |
Mechanisms of Dysfunction in Senescent Pulmonary Endothelium
D. Jane-Wit, H. J. Chun
|
j gerontol med sci
|
2012 |
SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF- 1 activity
L. B. Rivera, R. A. Brekken
|
The Journal of Cell Biology
|
2011 |
Comprehensive Physiology
Mary E Gerritsen
|
Comprehensive Physiology
|
2011 |
Modulation of TGF- signaling by endoglin in murine hemangioblast development and primitive hematopoiesis
L. Zhang, A. Magli, J. Catanese, Z. Xu, M. Kyba, R. C. R. Perlingeiro
|
Blood
|
2011 |
TGFβ signaling and congenital heart disease: Insights from mouse studies
Helen M. Arthur, Simon D. Bamforth
|
Birth Defect Res A
|
2011 |
Characterization of chicken endoglin, a member of the zona pellucida family of proteins, and its tissue expression
Elisa Rossi, Carmen Langa, Alvaro Gilsanz, Francisco J. Blanco, Juan Ayllón, Enrique Villar, Luisa M. Botella, Carlos Cabañas, Marlene Shaw, Carmelo Bernabeu
|
Gene
|
2011 |
Angiogenesis regulation by TGFβ signalling: clues from an inherited vascular disease
Marwa Mahmoud, Paul D. Upton, Helen M. Arthur
|
Biochem. Soc. Trans.
|
2011 |
Update on molecular diagnosis of hereditary hemorrhagic telangiectasia
Jennifer Richards-Yutz, Kathleen Grant, Elizabeth C. Chao, Susan E. Walther, Arupa Ganguly
|
Hum Genet
|
2010 |
Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT)
Luisa Ojeda-Fernandez, Laura Barrios, Alicia Rodriguez-Barbero, Lucia Recio-Poveda, Carmelo Bernabeu, Luisa M. Botella
|
Clinica Chimica Acta
|
2010 |
|